GLP-1 Meds: Potential Breakthrough in Addiction Treatment [Bloomberg]
- Jun 23, 2024
- 1 min read
Updated: Jun 24, 2024
Here at Pacific Northwest Medical Group, we’re excited to share promising news from the world of medical research that could benefit not only those looking to shed pounds but also individuals struggling with substance abuse disorders.
Recent studies have highlighted the potential of GLP-1 medications, like Ozempic, to aid in reducing alcohol consumption1.
A study led by Professor Christian Hendershot found that participants with alcohol use disorder who took semaglutide, the active ingredient in Ozempic, drank significantly less compared to those on a placebo2. This effect was noted to be stronger than any currently approved medications for alcoholism.
While these findings are preliminary and larger studies are needed for regulatory approval, they suggest that GLP-1s could be a game-changer for over 46 million Americans battling substance abuse disorders. These medications work by mimicking a hormone that suppresses appetite and cravings, which could explain the reduced consumption of alcohol and tobacco observed in users3.
Our clinic is dedicated to providing the latest and most effective treatments for weight loss and overall health. We invite you to join us on this journey towards a healthier lifestyle, where cutting-edge science meets compassionate care. Join us today and take the first step towards a brighter, healthier future!
Original and Full Article:
Reference: msn.com
Pacific Northwest Medical Group
6622 112th ST E, Puyallup WA 98373
253-340-2270
Book a FREE consult now <- Click There!
